RetinalGenix Technologies (RTGN) Gains from Investment Securities (2020 - 2026)
RetinalGenix Technologies recorded quarterly Gains from Investment Securities of $780000.0 in Q1 2026, up 371.66% quarter-over-quarter from $165375.0 in Q4 2025, and up 371.66% year-over-year from $165375.0 in Q1 2025.
RetinalGenix Technologies' Gains from Investment Securities history runs 7 years deep, the most recent figure standing at $780000.0 for Q1 2026.
- In Q1 2026, Gains from Investment Securities rose 371.66% year-over-year to $780000.0; the TTM figure through Mar 2026 stood at $780000.0 (up 235.25% YoY), while the FY2025 annual figure was $1.6 million, down 32.3% from the prior year.
- Gains from Investment Securities came in at $780000.0 for Q1 2026 at RetinalGenix Technologies, up from $165375.0 in the prior quarter.
- In the past five years, Gains from Investment Securities ranged from a high of $2.5 million in Q1 2024 to a low of -$1.1 million in Q4 2023.
- A 5-year average of $995842.6 and a median of $780000.0 in 2026 frame the typical range for Gains from Investment Securities.
- Across the five-year window, Gains from Investment Securities soared 2760.61% in 2022 and sank 339.75% in 2023, its largest moves.
- RetinalGenix Technologies' Gains from Investment Securities stood at $452433.0 in 2022, then tumbled by 339.75% to -$1.1 million in 2023, then jumped by 113.62% to $147751.0 in 2024, then increased by 11.93% to $165375.0 in 2025, then surged by 371.66% to $780000.0 in 2026.
- According to Business Quant data, Gains from Investment Securities over the past three periods registered $780000.0, $165375.0, and $790000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | RetinalGenix Technologies | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 780,000.00 |
| Mar 31, 2026 | 780,000.00 |
| Dec 31, 2025 | 165,375.00 |
| Dec 31, 2025 | 165,375.00 |
| Sep 30, 2025 | 790,000.00 |
| Sep 30, 2025 | 790,000.00 |
| Jun 30, 2025 | 790,000.00 |
| Jun 30, 2025 | 790,000.00 |
| Mar 31, 2025 | 165,375.00 |
| Mar 31, 2025 | 165,375.00 |
| Dec 31, 2024 | 147,751.00 |
| Dec 31, 2024 | 147,751.00 |
| Sep 30, 2024 | 2.47 Mn |
| Sep 30, 2024 | 2.47 Mn |
| Jun 30, 2024 | 2.47 Mn |
| Jun 30, 2024 | 2.47 Mn |
| Mar 31, 2024 | 2.49 Mn |
| Mar 31, 2024 | 2.49 Mn |
| Dec 31, 2023 | -1.08 Mn |
| Dec 31, 2023 | -1.08 Mn |
| Sep 30, 2023 | 300,000.00 |
| Sep 30, 2023 | 300,000.00 |
| Jun 30, 2023 | 2.36 Mn |
| Jun 30, 2023 | 2.36 Mn |
| Mar 31, 2023 | 194,873.00 |
| Mar 31, 2023 | 194,873.00 |
| Dec 31, 2022 | 452,433.00 |
| Dec 31, 2022 | 452,433.00 |
| Sep 30, 2022 | 2.36 Mn |
| Sep 30, 2022 | 2.36 Mn |
| Jun 30, 2022 | 1.88 Mn |
| Jun 30, 2022 | 1.88 Mn |
| Mar 31, 2022 | 1.88 Mn |
| Mar 31, 2022 | 1.88 Mn |
| Dec 31, 2021 | -21,509.00 |
| Dec 31, 2021 | -21,509.00 |
| Sep 30, 2021 | 82,500.00 |
| Sep 30, 2021 | 82,500.00 |
| Jun 30, 2021 | 82,500.00 |
| Jun 30, 2021 | 82,500.00 |
| Mar 31, 2021 | 197,826.00 |
| Mar 31, 2021 | 197,826.00 |
| Dec 31, 2020 | 106,318.00 |
| Dec 31, 2020 | 106,318.00 |